Abstract

Fluorescent analysis of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), keratoacanthoma and benign cutaneous lesions is carried out under initial phase of clinical trial in the National Oncological Center – Sofia. Excitation sources with maximum of emission at 365, 380, 405, 450 and 630 nm are applied for better differentiation between non-melanoma malignant cutaneous lesions fluorescence and spectral discrimination from the benign pathologies. Major spectral features are addressed and diagnostic discrimination algorithms based on lesions’ emission properties are proposed. The diagnostic algorithms and evaluation procedures found will be applied for development of an optical biopsy clinical system for skin cancer detection in the frames of National Oncological Center and other university hospital dermatological departments in our country.

© 2009 OSA/SPIE

PDF Article
More Like This
Pilot Clinical Study for Quantitative Spectral Diagnosis of Non-Melanoma Skin Cancer

Narasimhan Rajaram, Jason S. Reichenberg, Michael R. Migden, Tri H. Nguyen, and James W. Tunnell
BWB2 Biomedical Optics (BIOMED) 2010

Fluorescence Diagnosis in the characterization of basal cell carcinoma

Vitória Helena Maciel Coelho, Wagner Correr, Cristina Kurachi, Vanderlei Salvador Bagnato, and Cacilda da Silva Souza
LT2A.26 Latin America Optics and Photonics Conference (LAOP) 2012

Detection of Amelanotic Melanoma on the Basis of Nir Autofluorescence Features

Y. A. Khristoforova, I. A. Bratchenko, L. A. Bratchenko, A. A. Moryatov, S. V. Kozlov, and V. P. Zakharov
ETu1A.2 European Conference on Biomedical Optics (ECBO) 2021

References

You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access Optica Member Subscription